The urine biomarker PUR-4 is positively associated with the amount of Gleason 4 in human prostate cancers

Ball, Richard, Cardenas, Ryan, Winterbone, Mark, Yazbek Hanna, Marcelino, Parker, Christopher C., Hurst, Rachel, Brewer, Daniel ORCID: https://orcid.org/0000-0003-4753-9794, D'Sa, Lauren, Mills, Robert, Cooper, Colin ORCID: https://orcid.org/0000-0003-2013-8042 and Clark, Jeremy (2021) The urine biomarker PUR-4 is positively associated with the amount of Gleason 4 in human prostate cancers. Life, 11 (11). ISSN 2075-1729

Preview	PDF (2021_Ball et al._Life) - Published Version Available under License Creative Commons Attribution. Download (9MB) | Preview
Preview	PDF (life_1424157_supplementary) - Published Version Available under License Creative Commons Attribution. Download (399kB) | Preview

Abstract

The Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3), and high-risk (PUR-4) prostate cancer. In the current study we investigate how the PUR-4 status is linked to Gleason grade, prostate volume, and tumor volume as assessed from biopsy (n = 215) and prostatectomy (n = 9) samples. For biopsy data PUR-4 status alone was linked to Gleason Grade group (GG) (Spearman’s, ρ = 0.58, p < 0.001 trend). To assess the impact of tumor volume each GG was dichotomized into Small and Large volume cancers relative to median volume. For GG1 (Gleason Pattern 3 + 3) cancers volume had no impact on PUR-4 status. In contrast for GG2 (3 + 4) and GG3 (4 + 3) cancers PUR-4 levels increased in large volume cancers with statistical significance observed for GG2 (p = 0.005; Games-Howell). These data indicated that PUR-4 status is linked to the presence of Gleason Pattern 4. To test this observation tumor burden and Gleason Pattern were assessed in nine surgically removed and sectioned prostates allowing reconstruction of 3D maps. PUR-4 was not correlated with Gleason Pattern 3 amount, total tumor volume or prostate size. A strong correlation was observed between amount of Gleason Pattern 4 tumor and PUR-4 signature (r = 0.71, p = 0.034, Pearson’s). These observations shed light on the biological significance of the PUR biomarker and support its use as a non-invasive means of assessing the presence of clinically significant prostate cancer.

Item Type:	Article
Additional Information:	Funding Information: Funding: This study was possible thanks to the Movember Foundation GAP1 Urine Biomarker project, Prostate Cancer UK, The Masonic Charitable Foundation, The Bob Champion Cancer Trust, the King family, Big C Cancer Charity, The Andy Ripley Memorial Fund and the Stephen Hargrave Trust. The sponsors had no role in the design, execution, interpretation, or writing of the study.
Uncontrolled Keywords:	cancer,gleason pattern 4,prostate,pur,pur-4,urine,ecology, evolution, behavior and systematics,biochemistry, genetics and molecular biology(all),palaeontology,space and planetary science,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/1100/1105
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	05 Nov 2021 01:46
Last Modified:	20 Jun 2024 00:49
URI:	https://ueaeprints.uea.ac.uk/id/eprint/81985
DOI:	10.3390/life11111172

Downloads

Actions (login required)

View Item